| Ident. | Authors (with country if any) | Title |
|---|
| 000015 (2021) |
Kaho Shionoya [Japon] ; Masako Yamasaki [Japon] ; Shoya Iwanami [Japon] ; Yusuke Ito [Japon] ; Shuetsu Fukushi [Japon] ; Hirofumi Ohashi [Japon] ; Wakana Saso [Japon] ; Tomohiro Tanaka [Japon] ; Shin Aoki [Japon] ; Kouji Kuramochi [Japon] ; Shingo Iwami [Japon] ; Yoshimasa Takahashi [Japon] ; Tadaki Suzuki [Japon] ; Masamichi Muramatsu [Japon] ; Makoto Takeda [Japon] ; Takaji Wakita [Japon] ; Koichi Watashi [Japon] | Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro. |
| 000293 (2021) |
Keisuke Kuroda [Japon] ; Cong Li [Japon] ; Kiran Dhangar [Inde] ; Manish Kumar [Inde] | Predicted occurrence, ecotoxicological risk and environmentally acquired resistance of antiviral drugs associated with COVID-19 in environmental waters. |
| 000325 (2021) |
Masashi Ohe [Japon] ; Ken Furuya [Japon] ; Houman Goudarzi [Japon] | Multidrug treatment for COVID-19. |
| 000355 (2021) |
Risa Ebina-Shibuya [États-Unis] ; Ho Namkoong [États-Unis] ; Nobuyuki Horita [Japon] ; Hideaki Kato [Japon] ; Yu Hara [Japon] ; Nobuaki Kobayashi [Japon] ; Takeshi Kaneko [Japon] | Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials. |
| 000379 (2021) |
Annoor Awadasseid [Soudan] ; Yanling Wu [République populaire de Chine] ; Yoshimasa Tanaka [Japon] ; Wen Zhang [République populaire de Chine] | Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines. |
| 000550 (2021) |
Jun-Ichi Okada [Japon] ; Takashi Yoshinaga [Japon] ; Takumi Washio [Japon] ; Kohei Sawada [Japon] ; Seiryo Sugiura [Japon] ; Toshiaki Hisada [Japon] | Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study. |
| 000564 (2021) |
Masashi Ohe [Japon] ; Ken Furuya [Japon] ; Houman Goudarzi [Japon] | Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19? |
| 000593 (2021) |
Bin Zhou [Japon] ; Shinsuke Kojima [Japon] ; Atsuhiko Kawamoto [Japon] ; Masanori Fukushima [Japon] | COVID-19 pathogenesis, prognostic factors, and treatment strategy: Urgent recommendations. |
| 000609 (2020) |
Esmaeil Mehraeen [Iran] ; Seyed Ahmad Seyed Alinaghi [Iran] ; Ali Nowroozi [Iran] ; Omid Dadras [Japon] ; Sanam Alilou [Iran] ; Parnian Shobeiri [Iran] ; Farzane Behnezhad [Iran] ; Amirali Karimi [Iran] | A systematic review of ECG findings in patients with COVID-19. |
| 000659 (2020) |
Kyoji Ito [Japon] ; Norio Ohmagari [Japon] ; Ayako Mikami [Japon] ; Wataru Sugiura [Japon] | Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan. |
| 000699 (2020) |
Mohammed Mahbubul Matin [Bangladesh] ; Monir Uzzaman [Bangladesh, Japon] ; Shagir Ahammad Chowdhury [Bangladesh] ; Md Mosharef Hossain Bhuiyan [Bangladesh] | In vitro antimicrobial, physicochemical, pharmacokinetics and molecular docking studies of benzoyl uridine esters against SARS-CoV-2 main protease. |
| 000730 (2020) |
Md Sakirul Islam Khan [Japon] ; Hiroaki Nabeka [Japon] ; Sheikh Mohammad Fazle Akbar [Japon] ; Mamun Al Mahtab [Bangladesh] ; Tetsuya Shimokawa [Japon] ; Farzana Islam [Japon] ; Seiji Matsuda [Japon] | Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakers. |
| 000A40 (2021) |
Nobuaki Mori [Japon] ; Mitsuya Katayama [Japon] ; Shigenari Nukaga [Japon] | Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia. |
| 000A95 (2020) |
Chunxue Bai [République populaire de Chine] ; Sanjay H. Chotirmall [Singapour] ; Jordi Rello [Espagne, France] ; George A. Alba [États-Unis] ; Leo C. Ginns [États-Unis] ; Jerry A. Krishnan [États-Unis] ; Robert Rogers [États-Unis] ; Elisabeth Bendstrup [Danemark] ; Pierre-Regis Burgel [France] ; James D. Chalmers [Royaume-Uni] ; Abigail Chua [États-Unis] ; Kristina A. Crothers [États-Unis] ; Abhijit Duggal [États-Unis] ; Yeon Wook Kim [Corée du Sud] ; John G. Laffey [Irlande (pays)] ; Carlos M. Luna [Argentine] ; Michael S. Niederman [États-Unis] ; Ganesh Raghu [États-Unis] ; Julio A. Ramirez [États-Unis] ; Jordi Riera [Espagne] ; Oriol Roca [Espagne] ; Maximiliano Tamae-Kakazu [États-Unis] ; Antoni Torres [Espagne] ; Richard R. Watkins [États-Unis] ; Miriam Barrecheguren [Espagne] ; Mirko Belliato [Italie] ; Hassan A. Chami [Liban] ; Rongchang Chen [République populaire de Chine] ; Gustavo A. Cortes-Puentes [États-Unis] ; Charles Delacruz [États-Unis] ; Margaret M. Hayes [États-Unis] ; Leo M A. Heunks [Pays-Bas] ; Steven R. Holets [États-Unis] ; Catherine L. Hough [États-Unis] ; Sugeet Jagpal [États-Unis] ; Kyeongman Jeon [Corée du Sud] ; Takeshi Johkoh [Japon] ; May M. Lee [États-Unis] ; Janice Liebler [États-Unis] ; Gerry N. Mcelvaney [Irlande (pays)] ; Ari Moskowitz [États-Unis] ; Richard A. Oeckler [États-Unis] ; I Igo Ojanguren [Espagne] ; Anthony O'Regan [Irlande (pays)] ; Mathias W. Pletz [Allemagne] ; Chin Kook Rhee [Corée du Sud] ; Marcus J. Schultz [Pays-Bas] ; Enrico Storti [Italie] ; Charlie Strange [États-Unis] ; Carey C. Thomson [États-Unis] ; Francesca J. Torriani [États-Unis] ; Xun Wang [République populaire de Chine] ; Wim Wuyts [Belgique] ; Tao Xu [République populaire de Chine] ; Dawei Yang [République populaire de Chine] ; Ziqiang Zhang [République populaire de Chine] ; Kevin C. Wilson | Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020). |
| 000C75 (2020) |
Sho Iwasaka [Japon] ; Yuji Shono [Japon] ; Kentaro Tokuda [Japon] ; Kosuke Nakashima [Japon] ; Yuzo Yamamoto [Japon] ; Jun Maki [Japon] ; Yoji Nagasaki [Japon] ; Nobuyuki Shimono [Japon] ; Tomohiko Akahoshi [Japon] ; Tomoaki Taguchi [Japon] | Clinical improvement in a patient with severe coronavirus disease 2019 after administration of hydroxychloroquine and continuous hemodiafiltlation with nafamostat mesylate. |
| 000D90 (2020) |
Hiroyuki Fujii [Japon] ; Taisuke Tsuji [Japon] ; Tatsuya Yuba [Japon] ; Shunya Tanaka [Japon] ; Yoshifumi Suga [Japon] ; Aosa Matsuyama [Japon] ; Ayaka Omura [Japon] ; Shinsuke Shiotsu [Japon] ; Chieko Takumi [Japon] ; Seiko Ono [Japon] ; Masahito Horiguchi [Japon] ; Noriya Hiraoka [Japon] | High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19. |
| 000E46 (2020) |
Cevayir Coban [Japon] | The host targeting effect of chloroquine in malaria. |
| 001000 (2020) |
Akm Faizul Huq [Bangladesh] ; Md Fashiur Rahman [Bangladesh] ; Md Azizul Islam [Bangladesh] ; Syed A. Iqbal [Bangladesh] ; Azizur Rahman [Bangladesh] ; Syed Abul Hassan Md Abdullah [Bangladesh] ; Mamun Al Mahtab [Bangladesh] ; Sheikh Mf Akbar [Japon] | Real-life Management Strategy of COVID-19 Patients in Bangladesh with No Death: An Observational and Cohort Study. |
| 001001 (2020) |
Muhammad Ar Bhuyan [Bangladesh] ; Mamun Al Mahtab [Bangladesh] ; Eshita Ashab [Bangladesh] ; Md Jahirul Haque [Bangladesh] ; Syed Md M. Hoque [Bangladesh] ; Akm Faizul Huq [Bangladesh] ; Md Atikul Islam [Bangladesh] ; Nuzhat Choudhury [Bangladesh] ; Reema A. Alia [Bangladesh] ; Musarrat Mahtab [Bangladesh] ; Md Sakirul I. Khan [Japon] ; Sheikh Mf Akbar [Japon] | Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh. |
| 001191 (2020) |
Rajkumar Singh Kalra [Japon] ; Dhanendra Tomar [États-Unis] ; Avtar Singh Meena [Inde] ; Ramesh Kandimalla [Inde] | SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings. |
| 001298 (2021) |
Rupesh Agrawal [Singapour, Royaume-Uni] ; Ilaria Testi [Royaume-Uni] ; Cecilia S. Lee [États-Unis] ; Edmund Tsui [États-Unis] ; Marian Blazes [États-Unis] ; Jennifer E. Thorne [États-Unis] ; Annabelle A. Okada [Japon] ; Justine R. Smith [Australie] ; Peter J. Mccluskey [Australie] ; John H. Kempen [États-Unis, Éthiopie] ; Christoph Tappeiner [Suisse] ; Manisha Agarwal [Inde] ; Bahram Bodaghi [France] ; Quan Dong Nguyen [États-Unis] ; Vishali Gupta [Inde] ; Marc D. De Smet [Belgique] ; Manfred Zierhut [Allemagne] ; Carlos Pavesio [Royaume-Uni] | Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic. |
